Skip to main content
Premium Trial:

Request an Annual Quote

Horizon BCBS of NJ to Cover MDxHealth Prostate Cancer Test

NEW YORK (GenomeWeb) – MDxHealth announced today that its ConfirmMDx prostate cancer test has received a positive coverage policy decision from Horizon Blue Cross Blue Shield (BCBS) of New Jersey.

According to MDxHealth, Horizon BCBS is New Jersey’s largest insurer with more than 3.8 million members. With the latest policy decision, the company has secured coverage for ConfirmMDx with various BCBS affiliates including Independence Blue Cross and Highmark BCBS, as well as private payors such as Cigna and Priority Health. In September 2016, the test received in-network status for the California Medical Assistance Program.

"The positive coverage decision by Horizon BCBS of New Jersey further validates the clinical and economic value of ConfirmMDx for prostate cancer for health plans, patients, and physicians," MDxHealth CEO Jan Groen said in a statement. "We are pleased to see the growing number of healthcare plans providing coverage for our test, further improving patient outcomes and helping to reduce costs to the US healthcare system."

ConfirmMDx is an epigenetic tissue-based test for the early detection of prostate cancer, specifically aimed at addressing false-negative biopsy concerns. Early last year, it was included in the US 2016 National Comprehensive Cancer Network Guidelines for prostate cancer screening.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.